首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

2008169

麻疹-德国麻疹疫苗市场：依疫苗品牌、通路和地区划分

MR Vaccines Market, By Vaccine Brand (MR Vaccine, MRBEV (BE LTD.)), By Distribution Channel (Public, Private), By Geography (Commonwealth of Independent States (CIS) Countries, Latin America, Europe, Asia Pacific, Middle East, Africa)

出版日期: 2026年03月05日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2026年麻疹-德国麻疹疫苗市场规模估计为7,200万美元，预计2033年将达到1.016亿美元。预计2026年至2033年，该市场将以2.1%的复合年增长率成长。

分析范围		分析详情
基准年	2025	市场规模（2026 年）	7200万美元
效能数据	2020-2024	预测期	2026-2033
预测期（2026-2033 年）复合年增长率	2.10%	预计金额（2033 年）	1.016亿美元

麻疹-德国麻疹疫苗（MR疫苗）是活病毒疫苗，可预防麻疹和德国麻疹病毒感染。该疫苗透过刺激人体产生抗病毒防御机制（抗体）发挥作用。麻疹（也称为咳嗽麻疹、严重麻疹、麻疹样皮疹、红麻疹、德国麻疹和十日麻疹）是一种传染性极强的感染疾病。麻疹感染可导致严重的併发症，包括肺炎、中耳炎、鼻窦炎、癫痫、脑损伤甚至死亡。成人和5岁以下儿童发生严重併发症和死亡的风险更高。如果孕妇感染德国麻疹（也称为德国麻疹），可能导致流产、死产或胎儿出生缺陷。

市场动态

麻疹-德国德国麻疹(MR) 疫苗是一种皮下注射疫苗，用于为易感人群（包括青少年、青少年、儿童和婴儿）提供针对麻疹和德国麻疹的主动免疫。麻疹和德国德国麻疹(MR) 发病率的上升、MR 疫苗研发的临床试验正在进行、人们对免疫服务的认识不断提高、政府主导的疫苗接种运动宣传活动日益增多，以及非内部成长策略的日益普及（例如 MR 疫苗市场主要企业与世界卫生组织 (WHO)、联合国儿童基金会 (UNICEF) 和全球疫苗接种全球疫苗免疫联盟)免疫联盟阶段的合作期间

例如，据世界卫生组织（世卫组织）称，2020 年 1 月至 2021 年 4 月期间，非洲 8 个国家爆发了大规模麻疹疫情，由于免疫接种计划的延误和常规疫苗接种率低，导致数万名儿童受到影响。

本报告的主要特点

本报告指出了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
本文根据以下参数，介绍了全球麻疹-德国麻疹疫苗市场主要企业的概况：公司概况、产品系列、主要亮点、财务绩效和策略。
本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
《全球麻疹-德国麻疹疫苗市场》报告面向该行业的众多相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过分析全球麻疹-德国麻疹疫苗市场中使用的各种策略矩阵来促进决策。

独立国协（独联体）
- 俄罗斯
- 乌兹别克
- 哈萨克
- 乌克兰
- 土库曼
- 白俄罗斯
- 亚美尼亚
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 宏都拉斯
- 哥伦比亚
- 秘鲁
- 智利
欧洲
- 土耳其
- 亚洲
- 巴基斯坦
- 印尼
- 孟加拉
- 菲律宾
- 越南
- 泰国
- 缅甸
- 马来西亚
- 柬埔寨
- 尼泊尔
- 斯里兰卡
- 巴布亚纽几内亚
- 模里西斯
中东
- 阿拉伯聯合大公国
- 以色列
- 伊拉克
- 伊朗
- 沙乌地阿拉伯
- 约旦
- 卡达
- 阿曼
- 阿拉伯叙利亚共和国
非洲
奈及利亚
坦尚尼亚
刚果民主共和国
衣索比亚
肯亚
南非
埃及
摩洛哥
迦纳
乌干达
布吉纳法索
安哥拉
阿尔及利亚
辛巴威
突尼西亚
波札那
利比亚
纳米比亚

第七章竞争情势

热图分析
市占率分析
- PT Bio Farma
- Bio-Manguinhos
- Crucell Switzerland AG
- Serum Institute of India
- BE Vaccines

第八章

参考
分析方法

简介目录

Product Code: CMI4917

MR Vaccines Market is estimated to be valued at USD 72.0 Mn in 2026 and is expected to reach USD 101.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 2.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 72.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	2.10%	2033 Value Projection:	USD 101.6 Mn

Measles and rubella is a live virus vaccine that protects against infection with the measles and rubella viruses. It works by causing the body to produce its antiviral defenses (antibodies). Measles (also known as coughing measles, hard measles, morbilli, red measles, rubeola, and 10-day measles) is a highly contagious infectious disease. Measles infection can result in significant complications such as pneumonia, ear infections, sinus infections, convulsions (seizures), brain damage, and death. Adults and children under the age of 5 years are at a higher risk of serious complications and mortality. When pregnant women contract rubella (also known as German measles), it can result in miscarriages, stillbirths, or birth abnormalities in their unborn children.

Market Dynamics

Measles and Rubella (MR) vaccine is a subcutaneous injection for active immunization against Measles and Rubella in young adults, adolescents, children, and infants at risk. Increasing incidence of Measles and Rubella (MR), ongoing clinical trials to develop MR vaccines, growing awareness about immunization services, rising government initiatives to launch vaccine campaigns, and increasing adoption of inorganic growth strategies such partnerships by key players operating in the MR vaccines market with organizations such as WHO, UNICEF, and the GAVI Alliance are the major factors that are expected to drive growth of the MR vaccines market over the forecast period.

For instance, according to the World Health Organization (WHO), from January 2020 to April 2021, eight African nations experienced major measles outbreaks that affected tens of thousands of children, owing to delayed vaccination programs or low routine immunization coverage.

Key features of the study

This report provides an in-depth analysis of the MR vaccines market, and provides market size (US$ Mn. and No. of Doses in Mn.), and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the MR vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include PT Bio Farma, Bio-Manguinhos, BE Vaccines, Serum Institute of India, and Crucell Switzerland AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The MR vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the MR vaccines market

Market Segmentation

By Vaccine Brand
- MR Vaccine
- MRBEV (BE LTD.)
By Distribution Channel
- Public
- Private
By Region
- Commonwealth of Independent States (CIS) Countries
- Russia
- Uzbekistan
- Kazakhstan
- Ukraine
- Turkmenistan
- Belarus
- Armenia
- Latin America
- Brazil
- Argentina
- Mexico
- Honduras
- Colombia
- Peru
- Chile
- Europe
- Turkey
- Asia Pacific
- Pakistan
- Indonesia
- Bangladesh
- Philippines
- Vietnam
- Thailand
- Myanmar
- Malaysia
- Cambodia
- Nepal
- Sri Lanka
- Papua New Guinea
- Mauritius
- Middle East
- Israel
- UAE
- Iraq
- Iran
- Saudi Arabia
- Jordan
- Qatar
- Oman
- Syrian Arab Republic
- Africa
- South Africa
- Nigeria
- Tanzania
- Democratic Republic of Congo
- Ethiopia
- Kenya
- Egypt
- Morocco
- Ghana
- Uganda
- Burkina Faso
- Angola
- Algeria
- Zimbabwe
- Tunisia
- Botswana
- Libya
- Namibia
Key Players
- PT Bio Farma
- Bio-Manguinhos
- BE Vaccines
- Serum Institute of India
- Crucell Switzerland AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Vaccine Brand
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
  - Therapy Assessment
  - Disease Assessment
  - Epidemiological Assessment
  - Industry Assessment

4. MR Vaccines Market, By Vaccine Brand, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
MR Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
MRBEV (BE LTD.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. MR Vaccines Market, By Distribution Channel, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. MR Vaccines Market, By Region, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
Commonwealth of Independent States (CIS) Countries
- Market Size and Forecast, By Vaccine Brand, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Russia
  - Uzbekistan
  - Kazakhstan
  - Ukraine
  - Turkmenistan
  - Belarus
  - Armenia
Latin America
- Market Size and Forecast, By Vaccine Brand, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Honduras
  - Colombia
  - Peru
  - Chile
Europe
- Market Size and Forecast, By Vaccine Brand, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Turkey
  - Asia
- Market Size and Forecast, By Vaccine Brand, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Pakistan
  - Indonesia
  - Bangladesh
  - Philippines
  - Vietnam
  - Thailand
  - Myanmar
  - Malaysia
  - Cambodia
  - Nepal
  - Sri Lanka
  - Papua New Guinea
  - Mauritius
Middle East
- Market Size and Forecast, By Vaccine Brand, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - UAE
  - Israel
  - Iraq
  - Iran
  - Saudi Arabia
  - Jordan
  - Qatar
  - Oman
  - Syrian Arab Republic
Africa
- Market Size and Forecast, By Vaccine Brand, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Region/Country, 2026 - 2033, (USD Mn)
Nigeria
Tanzania
Democratic Republic of Congo
Ethiopia
Kenya
South Africa
Egypt
Morocco
Ghana
Uganda
Burkina Faso
Angola
Algeria
Zimbabwe
Tunisia
Botswana
Libya
Namibia

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- PT Bio Farma
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Bio-Manguinhos
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Crucell Switzerland AG
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Serum Institute of India
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- BE Vaccines
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
  - Analyst Views

8. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

麻疹-德国麻疹疫苗市场：依疫苗品牌、通路和地区划分

MR Vaccines Market, By Vaccine Brand (MR Vaccine, MRBEV (BE LTD.)), By Distribution Channel (Public, Private), By Geography (Commonwealth of Independent States (CIS) Countries, Latin America, Europe, Asia Pacific, Middle East, Africa)

市场动态